ERVW-1 and HIV infectious disease: Our laboratory has been using anti-Env Abs to target cytotoxic anti-HIV immunoconjugates (ICs) as a method to eliminate the persistent reservoir of latently-infected cells and eradicate HIV infection [10]–[15].